Dr Minh-Tuan NGUYEN KHAC

Spécialisations

• Neurochirurgie (ULiège, 2011)
• Management médical (ULB et UCL, 2017)
  
   

Centres d'intérêt

• Chirurgie tumorale cérébrale éveillée
• Neuro-oncologie adulte et pédiatrique
• Pathologies crâniennes et rachidiennes

Mandats

• Maître de stage pour la neurochirurgie
• Membre de la Society for Neuro-Oncology (USA)
• Membre de la Belgian Society of Paediatric Haematology and Oncology

Publications

Collaborations scientifiques

• Constitutive activation of casein kinase 2 in glioblastomas: Absence of class restriction and broad therapeutic potential. International Journal of Oncology 2016.

• Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy. Neuro Oncology 2014.

• Casein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma cells. International Journal of Oncology 2012.

• Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults. BMC Cancer 2009.

• Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas. International Journal of Oncology 2007.

• Chromosomal patterns of gene expression from microarray data : methodology, validation and clinical relevance in gliomas. BMC Bioinformatics 2006.

• Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells. BMC Cancer 2005.

• In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas. Clinical Cancer Research 2004.

• Modulation of the HSV-TK/ganciclovir bystander effect by n-butyrate in glioblastoma: correlation with gap-junction intercellular communication. International Journal of Oncology 2004.
   

​Communications

• Tumor-like MRS and PET findings in a case of radiation-induced brain necrosis, away from any tumor : an intriguing case report. Congrès de la Société Belge de Neurochirurgie (2009).
• Connexin-30 expression in high grade gliomas: correlation with survival and resistance to ionizing radiation. Congrès de la Société Belge de Neurochirurgie (2005).